Consolidated Statements of Earnings - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Net revenues	$ 25,096	$ 26,013	$ 26,153
Cost of sales	6,442	7,119	7,818
Excise taxes on products	4,408	4,902	5,312
Gross profit	14,246	13,992	13,023
Marketing, administration and research costs	2,327	2,432	2,150
Operating income	11,919	11,560	10,873
Interest and other debt expense, net	1,058	1,162	1,209
Loss on early extinguishment of debt	0	649	0
Net periodic defined benefits expense (reversal of expense)	(184)	(202)	(77)
(Income) losses from investments in equity securities	3,641	5,979	111
Impairment of JUUL equity securities	0	0	2,600
Loss on Cronos-related financial instruments	15	148	140
Earnings before income taxes	7,389	3,824	6,890
Provision for income taxes	1,625	1,349	2,436
Net earnings	5,764	2,475	4,454
Net losses attributable to noncontrolling interests	0	0	13
Net earnings attributable to Altria	$ 5,764	$ 2,475	$ 4,467
Per share data:
Basic earnings per share attributable to Altria (in usd per share)	$ 3.19	$ 1.34	$ 2.40
Diluted earnings per share attributable to Altria (in usd per share)	$ 3.19	$ 1.34	$ 2.40